Mesenchymal stromal cell treatment attenuates repetitive mild traumatic brain injury-induced persistent cognitive deficits via suppressing ferroptosis
Abstract The incidence of repetitive mild traumatic brain injury (rmTBI), one of the main risk factors for predicting neurodegenerative disorders, is increasing; however, its underlying mechanism remains unclear. As suggested by several studies, ferroptosis is possibly related to TBI pathophysiology...
| 出版年: | Journal of Neuroinflammation |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , |
| フォーマット: | 論文 |
| 言語: | 英語 |
| 出版事項: |
BMC
2022-07-01
|
| 主題: | |
| オンライン・アクセス: | https://doi.org/10.1186/s12974-022-02550-7 |
